-
1 . Periodical
Preliminary Safety, Pharmacological and Efficacy Data from Patients with Relapsed or Refractory B-Cell Malignancies Treated with the ICP-248, a Next Generation BCL2 Inhibitor
- 저자
- by Yi, Shuhua; Jin, Jie; Zhou, Keshu; Zhu, Huayuan; Ma, Kate, et al.
- 소스
- Blood; November 2023, Vol. 142 Issue: 1, Number 1 Supplement 1 p6149-6149, 1p